Light Horse Therapeutics develops small molecule therapeutics using a proprietary platform that identifies novel functional domains in disease-critical targets.

Tenvie Therapeutics is a biotechnology company developing small molecule therapeutics for neurological, cardiometabolic, and ophthalmic diseases.

nChroma Bio develops innovative genetic medicines using epigenetic editing and non-viral delivery technologies to treat chronic hepatitis B and D.

GC Therapeutics (GCTx) develops off-the-shelf iPSC-based cell therapy products for gastrointestinal, neurological, and immunological diseases using their innovative TFome platform.

Andalusia Labs provides digital asset technology solutions including a layer-2 blockchain, a crypto risk management marketplace, and a security-centric institutional platform, focusing on robust risk infrastructure for blockchain and web3 to support developers in creating advanced blockchain applications.